155 filings
Page 4 of 8
8-K
qzs dcskn
12 Aug 21
Kezar Life Sciences Reports Second Quarter Financial Results and Provides Business Updates
4:05pm
8-K
1d47kfcdof8cl
30 Jun 21
Submission of Matters to a Vote of Security Holders
6:03am
8-K
vqlkd3tk5
2 Jun 21
Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021
10:37am
DEFA14A
q3ky7up4
2 Jun 21
Additional proxy soliciting materials
12:00am
8-K
i0ivjbr9
1 Jun 21
Departure of Directors or Certain Officers
4:30pm
8-K
kfvb0sk6d7rub02
12 May 21
Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates
4:05pm
DEFA14A
g0t5b32dueum0q
29 Apr 21
Additional proxy soliciting materials
1:13pm
S-8
2eaah8t
11 Mar 21
Registration of securities for employees
4:47pm
8-K
jlbypy 82
11 Mar 21
Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates
4:03pm
8-K
lscu9r0oxj1sbib5 iix
11 Jan 21
Results of Operations and Financial Condition
5:10pm
8-K
91xlp redqg
5 Nov 20
Kezar Life Sciences Reports Third-Quarter 2020 Financial Results and Provides Business Updates
4:06pm
EFFECT
skjnggqy
24 Sep 20
Notice of effectiveness
12:15am
424B5
7f0q5 g4fi7gsk36
23 Sep 20
Prospectus supplement for primary offering
4:19pm
CORRESP
stp0wwh v4
21 Sep 20
Correspondence with SEC
12:00am
UPLOAD
7zguoajfkpupqmcpqpi
18 Sep 20
Letter from SEC
12:00am